The upregulation of the interstitial fibrotic markers MMP‐7, MMP‐8 and plasminogen activator inhibitor‐1 (PAI1) observed in people with T2D is indicative of a pro‐fibrotic environment. This evidence concerns the gene MMP7 and type 2 diabetes mellitus.